"10.1371_journal.pone.0135428","plos one","2015-08-12T00:00:00Z","Massimiliano Calabrese; Richard Reynolds; Roberta Magliozzi; Marco Castellaro; Aldo Morra; Antonio Scalfari; Gabriele Farina; Chiara Romualdi; Alberto Gajofatto; Marco Pitteri; Maria Donata Benedetti; Salvatore Monaco","Neurology Section, Department of Neurological and Movement Sciences, University of Verona, Verona, Italy; Neuroimaging Unit, Euganea Medica, Padova, Italy; Division of Brain Sciences, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, United Kingdom; Department of Cell Biology and Neuroscience, Istituto Superiore di Sanit√†, Rome, Italy; Department of Information Engineering, University of Padova, Padova, Italy; Department of Medicine, Division of Brain Sciences, Centre for Neuroscience, Wolfson Neuroscience Laboratories, Imperial College London, London, United Kingdom; Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy; Department of Biology, University of Padova, Padova, Italy","Conceived and designed the experiments: M. Calabrese. Performed the experiments: M. Calabrese M. Castellaro AM. Analyzed the data: M. Calabrese RR RM M. Castellaro AM AS GF CR AG MP MDB SM. Contributed reagents/materials/analysis tools: M. Calabrese M. Castellaro. Wrote the paper: M. Calabrese RR RM M. Castellaro AM AS GF CR AG MP MDB SM.","M. Calabrese received consultancy fees from Biogen Idec, Genzyme, Novartis Pharma, and Teva Pharmaceutical Industries towards this study. R. Reynolds received consultancy fees from EMD Serono towards this study. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2015","08","Massimiliano Calabrese","MC",12,TRUE,1,1,1,1,TRUE,TRUE,TRUE,5,"2;6;7;8;9",TRUE
